A decade ago, two patients received an innovative therapy for leukemia that revolutionized immunotherapy research. Today, chimeric antigen receptor (CAR) T cell therapy continues to evolve with advances in T cell and receptor engineering as a promising treatment for blood malignancies, solid tumors, and autoimmune diseases.
Explore this milestone article from Drug Discovery News to learn how scientists harnessed the body's defenses to develop CAR T cell therapy.